PSA Today Nov 2: Trade Talks Back On Boost Markets / Isuzu Outlook Remains Positive / SanBio, Sumi Dainippon Stroke Trials / GungHo New Growth Catalysts – Nikkei +2.56%
Japan Market Comment by Pelham Smithers, Julie Boote, Joel Scheiman and Thao NguyenNikkei ¥22,243.66 (+¥556.01 / +2.56%); Topix ¥1,658.76 (+¥26.71 / +1.64%); ¥/$112.98
Tags: Nabtesco (6268 JP), Daifuku (6383 JP), HMC (6305 JP), Ibiden (4062 JP), Keyence (6861 JP), Screen (7735 JP), Advantest (6857 JP), Tokyo Electron (8035 JP), Fujimi (5384 JP), Suzuki (7269 JP), Isuzu (7202 JP), Sumitomo Dainippon Pharma (4506 JP), SanBio (4592 JP), CareNet Inc (2150 JP), GungHo Online Entertainment (3765 JP), CyberAgent (4751 JP)
Main Points at a Glance
• US-China trade talks provide a boost to markets
• Isuzu: Higher expenses hurt Q2 results, but positive outlook for FY18
• SanBio, Sumitomo Dainippon up on stroke trials
• GungHo up on new growth catalysts
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.